196 related articles for article (PubMed ID: 16769216)
41. Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase.
Li S; Depetris RS; Barford D; Chernoff J; Hubbard SR
Structure; 2005 Nov; 13(11):1643-51. PubMed ID: 16271887
[TBL] [Abstract][Full Text] [Related]
42. Design and synthesis of potent, non-peptidic inhibitors of HPTPbeta.
Amarasinghe KK; Evdokimov AG; Xu K; Clark CM; Maier MB; Srivastava A; Colson AO; Gerwe GS; Stake GE; Howard BW; Pokross ME; Gray JL; Peters KG
Bioorg Med Chem Lett; 2006 Aug; 16(16):4252-6. PubMed ID: 16759857
[TBL] [Abstract][Full Text] [Related]
43. A focused library of protein tyrosine phosphatase inhibitors.
Comeau AB; Critton DA; Page R; Seto CT
J Med Chem; 2010 Sep; 53(18):6768-72. PubMed ID: 20731359
[TBL] [Abstract][Full Text] [Related]
44. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.
Taha MO; Bustanji Y; Al-Bakri AG; Yousef AM; Zalloum WA; Al-Masri IM; Atallah N
J Mol Graph Model; 2007 Mar; 25(6):870-84. PubMed ID: 17035054
[TBL] [Abstract][Full Text] [Related]
45. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
Pandey G; Saxena AK
J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
[TBL] [Abstract][Full Text] [Related]
46. Building predictive models for protein tyrosine phosphatase 1B inhibitors based on discriminating structural features by reassembling medicinal chemistry building blocks.
Yang C; Cross K; Myatt GJ; Blower PE; Rathman JF
J Med Chem; 2004 Nov; 47(24):5984-94. PubMed ID: 15537353
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and peptide incorporation of an unnatural amino acid containing activity-based probe for protein tyrosine phosphatases.
Shen K; Qi L; Ravula M; Klimaszewski K
Bioorg Med Chem Lett; 2009 Jun; 19(12):3264-7. PubMed ID: 19423347
[TBL] [Abstract][Full Text] [Related]
48. An enzyme-linked immunosorbent assay to measure insulin receptor dephosphorylation by PTP1B.
Zhang YL; Tam M; Kirincich S; Wan ZK; Wilson D; Wu JJ; Lee J; Tobin JF; Erbe DV
Anal Biochem; 2007 Jun; 365(2):174-84. PubMed ID: 17481567
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of protein tyrosine phosphatase 1B by diterpenoids isolated from Acanthopanax koreanum.
Na M; Oh WK; Kim YH; Cai XF; Kim S; Kim BY; Ahn JS
Bioorg Med Chem Lett; 2006 Jun; 16(11):3061-4. PubMed ID: 16545563
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug.
Boutselis IG; Yu X; Zhang ZY; Borch RF
J Med Chem; 2007 Feb; 50(4):856-64. PubMed ID: 17249650
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
[TBL] [Abstract][Full Text] [Related]
52. 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases.
Maccari R; Paoli P; Ottanà R; Jacomelli M; Ciurleo R; Manao G; Steindl T; Langer T; Vigorita MG; Camici G
Bioorg Med Chem; 2007 Aug; 15(15):5137-49. PubMed ID: 17543532
[TBL] [Abstract][Full Text] [Related]
53. Investigations of linker structure on the potency of a series of bidentate protein tyrosine phosphatase inhibitors.
Xie J; Seto CT
Bioorg Med Chem; 2005 Apr; 13(8):2981-91. PubMed ID: 15781408
[TBL] [Abstract][Full Text] [Related]
54. The development of potent non-peptidic PTP-1B inhibitors.
Dufresne C; Roy P; Wang Z; Asante-Appiah E; Cromlish W; Boie Y; Forghani F; Desmarais S; Wang Q; Skorey K; Waddleton D; Ramachandran C; Kennedy BP; Xu L; Gordon R; Chan CC; Leblanc Y
Bioorg Med Chem Lett; 2004 Feb; 14(4):1039-42. PubMed ID: 15013019
[TBL] [Abstract][Full Text] [Related]
55. Analyzing protein tyrosine phosphatases by phosphotyrosine analog integration.
Shen K
Methods; 2007 Jul; 42(3):234-42. PubMed ID: 17532510
[TBL] [Abstract][Full Text] [Related]
56. CoMFA based de novo design of pyridazine analogs as PTP1B inhibitors.
Nair PC; Sobhia ME
J Mol Graph Model; 2007 Jul; 26(1):117-23. PubMed ID: 17140831
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of a diverse series of phosphacoumarins with biological activity.
Li X; Zhang D; Pang H; Shen F; Fu H; Jiang Y; Zhao Y
Org Lett; 2005 Oct; 7(22):4919-22. PubMed ID: 16235922
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy.
Chen YT; Tang CL; Ma WP; Gao LX; Wei Y; Zhang W; Li JY; Li J; Nan FJ
Eur J Med Chem; 2013 Nov; 69():399-412. PubMed ID: 24090912
[TBL] [Abstract][Full Text] [Related]
59. Structure, modelling, and molecular dynamics studies of the inhibition of protein tyrosine phosphatase 1B by sulfotyrosine peptides.
Glover NR; Tracey AS
Biochem Cell Biol; 1999; 77(5):469-86. PubMed ID: 10593610
[TBL] [Abstract][Full Text] [Related]
60. Using yeast to screen for inhibitors of protein tyrosine phosphatase 1B.
Montalibet J; Kennedy BP
Biochem Pharmacol; 2004 Nov; 68(9):1807-14. PubMed ID: 15450946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
